Fund announced today a total investment of approximately JPY 1.39 billion (USD 8.8 million1) in six R&D projects for the ...

An international research team headed by scientists from Nanyang Technological University, Singapore and the Center for ...

The malaria parasite Plasmodium falciparum is becoming increasingly resistant to the artemisinin-based combination therapies (ACTs) currently in use. Researchers at the Bernhard Nocht Institute for ...

Brazilian researchers have developed a synthetic compound that has the potential to treat malaria and block its transmission.

Brazilian researchers have developed a synthetic compound that has the potential to treat malaria and block its transmission. The new molecule acts ...

After decades of struggle, researchers deploy a new arsenal of tools to protect children and stay ahead of drug-resistant parasites ...